283 results on '"Mosterd K"'
Search Results
52. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial
53. Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment
54. Resistentie voor vismodegib bij de behandeling van het basaalcelcarcinoom
55. Topicaal ingenol mebutaat versus 5% 5-fluorouracil versus 5% imiquimod versus fotodynamische therapie als behandeling van actinische keratosen: Een multicenter gerandomiseerde kosten effectiviteitsstudie: het protocol van de AKTI-studie
56. Een zeldzame oorzaak voor het basaalcelnaevussyndroom
57. Cutaan plaveiselcelcarcinoom na irradicale resectie van keratoacanthoom
58. Detectie en subtypering van het basaalcelcarcinoom met optical coherence tomografie: een prospectieve cohortstudie
59. 使用分级5-氨基酮戊酸20%和二级局部氨基乙酰丙酸甲酯通过局部光动力疗法来治疗表浅性基底细胞癌:随机对照试验结果
60. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial
61. A Clinical Prediction Model for Surgical Site Infections in Dermatological Surgery
62. Risk Factors for Surgical Site Infections in Dermatological Surgery
63. Bowen’s Disease: Long-term Results of Treatment with 5-Fluorouracil Cream, Photodynamic Therapy or Surgical Excision
64. Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment
65. Postzygotic mosaicism in basal cell naevus syndrome
66. Ambulatory Photodynamic Therapy for Superficial Basal Cell Carcinoma: An Effective Light Source?
67. Postzygotic mosaicism in basal cell naevus syndrome
68. Ambulatory Photodynamic Therapy for Superficial Basal Cell Carcinoma: An Effective Light Source?
69. Comparison of long-term cosmetic outcomes for different treatments of superficial basal cell carcinoma.
70. Development of a patient decision aid for superficial basal cell carcinoma.
71. Reliability of the Patient and Observer Scar Assessment Scale and a 4-point scale in evaluating linear facial surgical scars
72. Laser-mediated Photodynamic Therapy: An Alternative Treatment for Actinic Keratosis?
73. Subtyping basal cell carcinoma by clinical diagnosis versus punch biopsy
74. Subtyping Basal Cell Carcinoma by Clinical Diagnosis Versus Punch Biopsy
75. Subtyping Basal Cell Carcinoma by Clinical Diagnosis Versus Punch Biopsy
76. Epidermal Cyst Formation and Hyperkeratosis in a Patient Treated with Vismodegib for Locally Advanced Basal Cell Carcinoma
77. Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial
78. Preoperative Management of Antithrombotic Medication in Mohs Micrographic Surgery
79. Bowen’s Disease: A Six-year Retrospective Study of Treatment with Emphasis on Resection Margins
80. Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma
81. Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma
82. FC20 Three non-invasive treatment options for superficial basal cell carcinoma: photodynamic therapy versus imiquimod versus 5-fluorouracil. TTOP-sBCC Trial
83. Removal of basal-cell carcinoma of the face – Author's reply
84. Histology-based Treatment of Basal Cell Carcinoma
85. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
86. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
87. Prognostic Factors for Treatment Failure of Photodynamic Therapy and 5-Fluorouracil in Bowen's Disease.
88. Interobserver agreement on line-field confocal optical coherence tomography image markers in keratinocyte carcinomas and precursor lesions.
89. Hedgehog Pathway and Programmed Cell Death Protein-1 Inhibitors for Advanced Basal Cell Carcinoma.
90. European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes).
91. Detection of PTCH1 Copy-Number Variants in Mosaic Basal Cell Nevus Syndrome.
92. 'Pitfalls for differentiating basal cell carcinoma from non-basal cell carcinoma on optical coherence tomography: A clinical series'.
93. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen's disease: A multicenter randomized controlled trial.
94. Effectiveness of a patient decision aid for patients with superficial basal cell carcinoma: A pre- and post-implementation study.
95. Optical coherence tomography for diagnosing recurrent or residual basal cell carcinoma after topical treatment: A diagnostic cohort study.
96. Line-field confocal optical coherence tomography can help differentiating melanoma from pigmented basal cell carcinoma: A case report.
97. [Basal cell nevus syndrome: the interface between dentistry and dermatology].
98. Molecular mechanism of extracutaneous tumours in patients with basal cell nevus syndrome.
99. A cohort study on detection and subtyping of basal cell carcinoma with optical coherence tomography: The additional value of distant diagnosis by an expert.
100. Corrigendum: Accuracy of Optical Coherence Tomography for Subtyping Basal Cell Carcinoma: Using Histopathology of Biopsy and Entire Lesion as Reference Standard.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.